Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 6.96M | $ 486.33M | $ 493.29M |
3/31/2025 | $ 7.35M | $ 511.42M | $ 518.77M |
12/31/2024 | $ 8.09M | $ 538.55M | $ 546.64M |
9/30/2024 | $ 5.49M | $ 541.22M | $ 546.71M |
6/30/2024 | $ 6M | $ 542.52M | $ 548.52M |
3/31/2024 | $ 6.51M | $ 544M | $ 550.51M |
12/31/2023 | $ 7.01M | $ 544.91M | $ 551.92M |
9/30/2023 | $ 7.47M | $ 543.1M | $ 550.57M |
6/30/2023 | $ 7.94M | $ 539.9M | $ 547.84M |
3/31/2023 | $ 8.39M | $ 535.74M | $ 544.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for VANDA PHARMACEUTICALS INC is calculated as follows: Debt [ $ 11.56M ] + Equity [ $ 440.57M ]
(=) Inv. Capital [ $ 452.13M ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.11B |
average | $ 759.87M |
median | $ 302.55M |
std | $ 1B |